Penicillin Allergy Delabeling: An Antibiotic Stewardship Initiative

Original release date: June 11, 2024; Termination date: May 16, 2027.

Download the webinar slides as full page slides or in handout format.

Continuing Education Credit(s)

This webinar has been approved for 1 AMA PRA Category 1 Credit™.

To request a certificate, you must first view the Penicillin Allergy Delabeling webinar and then complete the Evaluation/Certificate Request Form. Physicians will receive a CME Certificate and other learners will receive a Certificate of Attendance*

Webinar Overview

This activity is designed for healthcare providers including physicians and pharmacists. Topics included are an update on recent guidelines for addressing penicillin allergy; the benefits of penicillin allergy delabeling; and identifying appropriate candidates for oral amoxicillin challenge. Participants should become familiar with safe and effective ways to delabel patients identified as penicillin allergic who are admitted to the hospital.

Part II, a CME activity with case studies is also available.

Target Audience

This activity is designed for healthcare providers including physicians, pharmacists, infection preventionists or other facility antibiotic stewardship stakeholders.

Learning Objectives

At the conclusion of the webinar, participants will will feel more confident in their ability to:
  1. Discuss the risks of having a penicillin allergy label.
  2. Obtain a penicillin allergy history to determine risk of new/repeated allergic reaction upon administration of penicillin.
  3. Safely perform an amoxicillin challenge.
  4. Proactively remove a patient’s penicillin allergy label when appropriate.
  5. Implement a penicillin allergy delabeling process and program.

Webinar Presenter

Shazia Lutfeali, MD

Shazia Lutfeali, MD, Allergy and Immunology Assistant Professor, Departments of Medicine and Pediatrics Cedars-Sinai Medical Center.

Dr. Lutfeali treats both hospitalized and clinic patients with a variety of allergic and immunologic conditions including drug allergies, food allergies, environmental allergies, chronic hives, severe asthma, and atopic dermatitis. During her training, she developed a strong interest in drug allergy and specifically the importance of penicillin allergy delabeling. Her research focused on rates of penicillin allergy relabeling and methods to prevent inappropriate allergy relabeling.


Resources for Further Study

LAC DPH Penicillin Allergy Delabeling Toolkit for Hospitals
LAC DPH Antimicrobial Stewardship Program homepage

Accreditation Statement

California Medical Association accredited CME provider logo

The Los Angeles County Department of Public Health is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

The Los Angeles County Department of Public Health designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

*Other learners receive a Certificate of Attendance. Participation in CE coursework designated for AMA PRA Category 1 Credits™ is considered acceptable CE by the CA Board of Registered Nursing and the CA Board of Pharmacy if the coursework pertains to the practice of nursing or pharmacy respectively. Please contact your board with questions.

Disclosure

No relevant financial relationships were disclosed by the authors or the planners. This activity is offered by an accredited CMA-CME provider and is not commercially supported.

Contact Information